Incidence and prevalence of primary hyperparathyroidism in a racially mixed population

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 3, 2013, Pages 1122-1129

  Yeh, Michael W ^a,d   Ituarte, Philip H G ^a   Zhou, Hui Cynthia ^b   Nishimoto, Stacie ^a   In Lu Amy Liu, ^b   Harari, Avital ^a   Haigh, Philip I ^c   Adams, Annette L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Kaiser Permanente Southern California ^*  (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d Section of Endocrine Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; AGED; AGING; ARTICLE; ASIAN; CALCIUM BLOOD LEVEL; CAUCASIAN; CHRONIC DISEASE; DESCRIPTIVE RESEARCH; FEMALE; HISPANIC; HUMAN; HYPERCALCEMIA; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; NEGRO; PARATHYROID HORMONE BLOOD LEVEL; POPULATION RESEARCH; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RACE DIFFERENCE; REFERENCE VALUE; SEX DIFFERENCE; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; CALIFORNIA; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERPARATHYROIDISM, PRIMARY; INCIDENCE; MALE; MIDDLE AGED; PARATHYROID HORMONE; PREVALENCE; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84874883807     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4022     Document Type: Article

References (26)

1. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002;17:N18-N23. (Pubitemid 35222308)
2. Christensson T, Hellström K, Wengle B, Alveryd A, Wikland B. Prevalence of hypercalcaemia in a health screening in Stockholm. Acta Med Scand. 1976;200:131-137.
3. Wermers RA, Khosla S, Atkinson EJ, et al. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med. 1997;126(6):433-440. (Pubitemid 27114471)
4. Yu N, Donnan PT, Murphy MJ, Leese GP. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol. 2009;71(4):485-493.
5. Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684): 145-58.
6. Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: An update on the changing epidemiology of the disease. J Bone Miner Res. 2006;21(1):171-177. (Pubitemid 43023239)
7. Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, et al. Incidence of diabetes in youth in the United States. JAMA. 2007;297(24):2716-2724. (Pubitemid 47001097)
8. Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM. Prevalence and co-occurrence of pelvic floor disorders in communitydwelling women. Obstet Gynecol. 2008;111(3):678-685. (Pubitemid 351654073)
9. Pagano M, Gauvreau K. Principles of Biostatistics. Belmont, CA: Duxbury Press; 1993.
10. Sahai H, Khurshid A. Confidence intervals for the mean of a Poisson distribution: A review. Biometrical J. 1993;35(7):857-867.
11. Nilsson I-L, Wadsten C, Brandt L, Rastad J, Ekbom. Mortality in sporadic primary hyperparathyroidism: Nationwide cohort study of multiple parathyroid gland disease. Surgery. 2004;136(5):981-987. (Pubitemid 39452296)
12. Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ. 2003;327(7414):530-534.
13. Richert L, Trombetti A, Herrmann FR, et al. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly. 2009;139(27-28):400-404.
14. Yeh MW, Wiseman JE, Ituarte PH, et al. Surgery for primary hyperparathyroidism: are the consensus guidelines being followed? Ann Surg. 2012;255(6):1179-1183.
15. Aloia JF. African Americans, 25-hydroxyvitamin D, and osteoporosis: a paradox. Am J Clin Nutr. 2008;88(2):545S-550S.
16. Aloia JF, Chen DG, Chen H. The 25(OH)D/PTH threshold in black women. J Clin Endocrinol Metab. 2010;95(11):5069-5073.
17. Cauley JA, Danielson ME, Boudreau R, et al. Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's Health Initiative (WHI). J Bone Miner Res. 2011;26(10):2378-2388.
18. Golden SH, Brown A, Cauley JA, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2012;97:E1579-E1639.
19. Wright N, Chen L, Niu J, et al. Defining physiologically 'normal' vitamin D in African Americans. Osteoporos Int. 2012;23:2283-2289.
20. Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res. 1991;6(S2):S51-S59.
21. Bilezikian JP, Khan AA, Potts JT Jr, the Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab. 2009;94(2): 335-339.
22. Dedov II, Mokrysheva NG, Mirnaya SS, et al. Epidemiology of primary hyperparathyroidism in Russia (the first results from the database of federal state institution 'Endocrinological Research Centre'). Problemy Endokrinologii. 2011;57(3):3-10.
23. Carnaille BM, Pattou FN, Oudar C, Lecomte-Houcke MC, Rocha JE, Proye CA. Parathyroid incidentalomas in normocalcemic patients during thyroid surgery. World J Surg. 1996;20(7):830-834. (Pubitemid 26281911)
24. Udelsman R, Pasieka JL, Sturgeon C, Young JEM, Clark OH. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J Clin Endocrinol Metab. 2009;94(2):366-372.
25. Vassilopoulou-Sellin R, Newman BM, Taylor SH, Guinee VF. Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center. Cancer. 1993;71(4):1309-1312. (Pubitemid 23054924)
26. Glendenning P, Stuckey BG. The estimated prevalence of familial hypocalciuric hypercalcemia (FHH). Calcif Tissue Int. 2002;70(6): 512.